Business Context and Reporting Period
Company: Research Solutions, Inc. (RSSS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2024
Business Overview: A vertical SaaS and AI company providing software platforms for research-intensive organizations. The company offers discovery tools, access to scientific, technical, and medical (STM) content, and reference management solutions. It operates as a fully remote company with subsidiaries in the U.S. and Mexico.
Key Financial Metrics
| Metric | Q1 2024 (Three Months Ended Sept 30) | Q1 2023 (Three Months Ended Sept 30) |
|---|---|---|
| Total Revenue | $12,044,482 | $10,060,971 |
| Gross Profit | $5,765,876 | $4,031,565 |
| Gross Margin | 47.9% | 40.1% |
| Operating Income | $646,691 | ($1,098,952) |
| Net Income | $669,004 | ($988,043) |
| Diluted EPS | $0.02 | ($0.04) |
| Cash and Equivalents (End of Period) | $6,924,773 | $9,882,064 |
| Operating Cash Flow | $843,119 | ($755,571) |
| Contingent Earnout Liability | $12,298,114 | N/A (Not reported in 2023 Q1) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 19.7% year-over-year. Platform revenue surged 66.5% to $4.33M, driven by new deployments and the Scite acquisition. Transaction revenue grew 3.4% to $7.71M.
- Profitability Turnaround: The company reported a net income of $669,004, a significant improvement from a net loss of $988,043 in the prior year. Operating income turned positive ($646,691) from a loss of $1.1M.
- Margin Expansion: Gross margin improved by 7.8 percentage points to 47.9%, primarily due to lower personnel costs in the Platform segment and higher copyright margins in Transactions.
- Expense Management: Total operating expenses remained flat (-0.2%). While Sales & Marketing (+73.8%) and Technology (+10.3%) increased due to the Scite acquisition, General & Administrative expenses decreased 24.1% due to lower legal and personnel costs.
- Amortization Impact: Depreciation and amortization expenses increased 423.5% to $312,095, reflecting the amortization of intangible assets from recent acquisitions (Scite and ResoluteAI).
Outlook, Risks, and Contingencies
- Acquisition Integration: The company continues to integrate Scite (acquired Dec 2023) and ResoluteAI (acquired July 2023). The Scite acquisition includes a contingent earnout liability valued at $12.3M as of September 30, 2024, based on future revenue targets.
- Liquidity: The company maintains a healthy cash position of $6.9M. It secured a $500,000 revolving line of credit with PNC Bank in April 2024, which remains undrawn.
- Stock-Based Compensation: The company utilizes a Long-Term Equity Bonus Plan (LTEBP) with market-based vesting conditions tied to stock price targets ($3.00 to $6.00 VWAP). Stock-based compensation expense decreased 29.4% year-over-year.
- Risk Factors: Management notes risks related to inflation, interest rates, and foreign currency fluctuations (holding cash in Euros and British Pounds). There are no material changes to risk factors from the previous 10-K.
- Guidance: The filing does not contain specific forward-looking financial guidance or revenue targets for future periods.
Investor Verification Checklist
- Acquisition Valuation: Verify the provisional nature of the goodwill ($13.2M) and intangible assets ($8.1M) related to the Scite acquisition and the potential for future adjustments.
- Contingent Liability: Monitor the $12.3M contingent earnout liability for Scite, which is dependent on achieving specific annual recurring revenue targets by January 31, 2025.
- Revenue Quality: Assess the sustainability of the 66.5% growth in Platform revenue to determine if it is driven by recurring subscriptions or one-time expansion.
- Cash Burn vs. Generation: Confirm the trend of positive operating cash flow ($843K) continues, especially given the high amortization charges that do not impact cash flow.
- Share Count: Note the increase in weighted average diluted shares (33.2M) compared to the prior year (27.1M) due to the inclusion of unvested restricted stock in the diluted calculation.